In utero exposure to antivirals not found to increase birth defects

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1317, 2010-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The prevalence of birth defects after in utero nelfinavir exposure does not differ significantly from the population-based prevalence

Reactions Weekly, Vol. 1, Iss. 1009, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

ARV exposure and risk of birth defects examined

Reactions Weekly, Vol. 1, Iss. 1312, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

In utero valproic acid exposure may increase risk of congenital disorders

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Antineoplastics: Premature birth after in utero exposure and maternal gastrointestinal and kidney toxicities: 5 cases

Reactions Weekly, Vol. 1, Iss. 1337, 2011-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Thiamazole: Aplasia cutis congenita and skull defects in a neonate following in utero exposure: case report

Reactions Weekly, Vol. 1, Iss. 1156, 2007-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite